Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

Abstract TNFR-associated factors (TRAFs) constitute a family of adapter proteins that associate with particular TNF family receptors. Humans and mice contain six TRAF genes, but little is known about their in vivo expression at the single cell level. The in vivo locations of TRAF1, TRAF2, TRAF5, and TRAF6 were determined in human and mouse tissues by immunohistochemistry. Striking diversity was observed in the patterns of immunostaining obtained for each TRAF family protein, suggesting their expression is independently regulated in a cell type-specific manner. Dynamic regulation of TRAFs was observed in cultured PBLs, where anti-CD3 Abs, mitogenic lectins, and ILs induced marked increases in the steady-state levels of TRAF1, TRAF2, TRAF5, and TRAF6. TRAF1 was also highly inducible by CD40 ligand in cultured germinal center B cells, whereas TRAF2, TRAF3, TRAF5, and TRAF6 were relatively unchanged. Analysis of 83 established human tumor cell lines by semiquantitative immunoblotting methods revealed tendencies of certain cancer types to express particular TRAFs. For example, expression of TRAF1 was highly restricted, with B cell lymphomas consistently expressing this TRAF family member. Consistent with results from tumor cell lines, immunohistochemical analysis of 232 non-Hodgkin lymphomas revealed TRAF1 overexpression in 112 (48%) cases. TRAF1 protein levels were also elevated in circulating B cell chronic lymphocytic leukemia specimens (n = 49) compared with normal peripheral blood B cells (p = 0.01), as determined by immunoblotting. These findings contribute to an improved understanding of the cell-specific roles of TRAFs in normal tissues and provide evidence of altered TRAF1 expression in lymphoid malignancies.

Bibliography

Zapata, J. M., Krajewska, M., Krajewski, S., Kitada, S., Welsh, K., Monks, A., McCloskey, N., Gordon, J., Kipps, T. J., Gascoyne, R. D., Shabaik, A., & Reed, J. C. (2000). TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies. The Journal of Immunology, 165(9), 5084–5096.

Authors 12
  1. Juan M. Zapata (first)
  2. Maryla Krajewska (additional)
  3. Stanislaw Krajewski (additional)
  4. Shinichi Kitada (additional)
  5. Kate Welsh (additional)
  6. Anne Monks (additional)
  7. Natalie McCloskey (additional)
  8. John Gordon (additional)
  9. Thomas J. Kipps (additional)
  10. Randy D. Gascoyne (additional)
  11. Ahmed Shabaik (additional)
  12. John C. Reed (additional)
References 63 Referenced 116
  1. Arch, R. H., R. W. Gedrich, C. B. Thompson. 1998. Tumor necrosis factor receptor-associated factors (TRAFs)–a family of adapter proteins that regulates life and death. Genes Dev. 12: 2821 (10.1101/gad.12.18.2821)
  2. McWhirter, S., S. Pullen, J. Holton, J. Crute, M. Kehry, T. Alber. 1999. Cristalographic analyses of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. USA 96: 8408 (10.1073/pnas.96.15.8408)
  3. Park, Y., V. Burkitt, A. Villa, L. Tong, H. Wu. 1999. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398: 533 (10.1038/19110)
  4. Ye, H., Y. Park, M. Kreishman, E. Kieff, H. Wu. 1999. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4: 321 (10.1016/S1097-2765(00)80334-2)
  5. Gedrich, R. W., M. C. Gilfillan, C. S. Duckett, J. L. Van Dongen, C. B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271: 12852 (10.1074/jbc.271.22.12852)
  6. Boucher, L.-M., L. E. M. Marengère, Y. Lu, S. Thukral, T. W. Mak. 1997. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem. Biophys. Res. Commun. 233: 592 (10.1006/bbrc.1997.6509)
  7. Pullen, S. S., T. T. Dang, J. J. Crute, M. R. Kehry. 1999. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs): binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 274: 14246 (10.1074/jbc.274.20.14246)
  8. Leo, E., K. Welsh, S. Matsuzawa, J. M. Zapata, S. Kitada, R. Mitchell, K. R. Ely, J. C. Reed. 1999. Differential requirements for TRAF-family proteins in CD40-mediated induction of NF-κB and JNK activation. J. Biol. Chem. 274: 22414 (10.1074/jbc.274.32.22414)
  9. Pullen, S., H. Miller, D. Everdeen, T. Dang, J. Crute, M. Kehry. 1998. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-ogliomerization. Biochemistry 37: 11830 (10.1021/bi981067q)
  10. Yamamoto, H., T. Kishimoto, S. Minamoto. 1998. NF-κB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J. Immunol. 161: 4753 (10.4049/jimmunol.161.9.4753)
  11. Thome, M., K. Hofmann, K. Burns, F. Martinon, J. L. Bodmer, C. Mattmann, J. Tschopp. 1998. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8: 885 (10.1016/S0960-9822(07)00352-1)
  12. Song, H. Y., C. H. Régnier, C. J. Kirschning, D. V. Goeddel, M. Rothe. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94: 9792 (10.1073/pnas.94.18.9792)
  13. Shi, C. S., A. Leonardi, J. Kyriakis, U. Siebenlist, J. H. Kehrl. 1999. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related. J. Immunol. 163: 3279 (10.4049/jimmunol.163.6.3279)
  14. Baud, V., Z.-G. Liu, B. Bennett, N. Suzuki, Y. Xia, M. Karin. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13: 1297 (10.1101/gad.13.10.1297)
  15. Hsu, H., J. Huang, H. Shu, V. Baichwal, D. V. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387 (10.1016/S1074-7613(00)80252-6)
  16. Hoeflich, K. P., W. C. Yeh, Z. Yao, T. W. Mak, J. R. Woodgett. 1999. Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1). Oncogene 18: 5814 (10.1038/sj.onc.1202975)
  17. Nishitoh, H., M. Saitoh, Y. Mochida, K. Takeda, H. Nakano, M. Rothe, K. Miyazono, H. Ichijo. 1998. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2: 389 (10.1016/S1097-2765(00)80283-X)
  18. Speiser, D. E., S. Y. Lee, B. Wong, J. Arron, A. Santana, Y. Y. Kong, P. S. Ohashi, W. Choi. 1997. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185: 1777 (10.1084/jem.185.10.1777)
  19. Lee, S. Y., A. Reichlin, A. Santana, K. A. Sokol, M. C. Nussenzweig, Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7: 703 (10.1016/S1074-7613(00)80390-8)
  20. Xu, Y., G. Cheng, D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5: 407 (10.1016/S1074-7613(00)80497-5)
  21. Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al 1997. Early lethality, functional NF- κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715 (10.1016/S1074-7613(00)80391-X)
  22. Nguyen, L. T., G. S. Duncan, C. Mirtsos, M. Ng, D. E. Speiser, A. Shahinian, M. W. Marino, T. W. Mak, P. S. Ohashi, W. C. Yeh. 1999. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11: 379 (10.1016/S1074-7613(00)80113-2)
  23. Lomaga, M., W.-C. Yeh, I. Sarosi, G. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13: 1015 (10.1101/gad.13.8.1015)
  24. Nakano, H., S. Sakon, H. Koseki, T. Takemori, K. Tada, M. Matsumoto, E. Munechika, T. Sakai, T. Shirasawa, H. Akiba, et al 1999. Targeted disruption of TRAF5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. USA 96: 9803 (10.1073/pnas.96.17.9803)
  25. Krajewski, S., J. M. Zapata, M. Krajewski, T. V. Arsdale, A. Shabaik, R. D. Gascoyne, J. C. Reed. 1997. Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family. J. Immunol. 159: 5841 (10.4049/jimmunol.159.12.5841)
  26. Krajewska, M., S. Krajewski, J. M. Zapata, T. Van Arsdale, R. D. Gascoyne, K. Berern, D. McFadden, A. Shabaik, J. Hugh, C. Reynolds, C. V. Clevenger, J. C. Reed. 1998. TRAF-4 expression in epithelial progenitor cells. Am. J. Pathol. 152: 1549
  27. Reed, J., L. Meister, M. Cuddy, C. Geyer, D. Pleasure. 1991. Differential expression of the Bcl-2 proto-oncogene in neuroblastomas and other human neural tumors. Cancer Res. 5l: 6529
  28. Kononen, J., L. Bubendorf, A. Kallioniemi, M. Bärlund, P. Schraml, S. Leighton, J. Torhorst, M. J. Mihatsch, G. Sauter, O.-P. Kallioniemi. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844 (10.1038/nm0798-844)
  29. Rosenberg, S. A.. 1982. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage. Cancer 49: 2112 (10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2)
  30. Harris, N. L., E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. D. Wolf-Peeters, B. Falini, K. C. Gatter. 1994. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361 (10.1182/blood.V84.5.1361.bloodjournal8451361)
  31. Krajewski, S., M. Krajewska, A. Shabaik, T. Miyashita, H.-G. Wang, J. C. Reed. 1994. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145: 1323
  32. Krajewski, S., M. Krajewska, L. M. Ellerby, K. Welsch, Z. Xie, Q. L. Deveraux, G. S. Salvesen, D. E. Bredesen, R. E. Rosenthal, G. Fiskum, J. C. Reed. 1999. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA 96: 5752 (10.1073/pnas.96.10.5752)
  33. Krajewski, S., M. Krajewska, A. Shabaik, H.-G. Wang, S. Irie, L. Fong, J. C. Reed. 1994. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54: 5501
  34. Krajewski, S., J. M. Zapata, J. C. Reed. 1996. Detection of multiple antigens on Western blots. Anal. Biochem. 236: 221 (10.1006/abio.1996.0160)
  35. Zapata, J. M., R. Takahashi, G. S. Salvesen, J. C. Reed. 1998. Granzyme release and caspase activation in activated human T-lymphocytes. J. Biol. Chem. 273: 6916 (10.1074/jbc.273.12.6916)
  36. McCloskey, N., J. D. Pound, M. J. Holder, J. M. Williams, L. M. Roberts, J. M. Lord, J. Gordon. 1999. The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40. Eur. J. Immunol. 29: 3236 (10.1002/(SICI)1521-4141(199910)29:10<3236::AID-IMMU3236>3.0.CO;2-T)
  37. Kitada, S., J. Andersen, S. Akar, J. M. Zapata, S. Takayama, S. Krajewski, H.-G. Wang, X. Zhang, F. Bullrich, C. M. Croce, et al 1998. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91: 3379 (10.1182/blood.V91.9.3379)
  38. Kitada, S., M. Krajewska, X. Zhang, D. Scudiero, J. M. Zapata, H. G. Wang, A. Shabaik, G. Tudor, S. Krajewski, T. G. Myers, et al 1998. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol. 152: 51
  39. Weinstein, J., T. Myers, P. O’Connor, S. Friend, A. J. Fornace, K. Kohn, T. Fojo, S. Bates, L. Rubinstein, N. Anderson, et al 1997. An information-intensive approach to the molecular pharmacology of cancer. Science 17: 343 (10.1126/science.275.5298.343)
  40. Takayama, S., S. Krajewski, M. Krajewska, S. Kitada, J. M. Zapata, K. Kochel, D. Knee, D. Scudiero, G. Tudor, G. J. Miller, et al 1998. Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 58: 3116
  41. Pegoraro, L., A. Palumbo, J. Erikson, M. Falda, B. Giovanazzo, B. S. Emanuel, G. Rovera, P. C. Nowell, C. M. Croce. 1984. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc. Natl. Acad. Sci. USA 81: 7166 (10.1073/pnas.81.22.7166)
  42. Rothe, M., S. C. Wong, W. J. Henzel, D. V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78: 681 (10.1016/0092-8674(94)90532-0)
  43. Rothe, M., M.-G. Pan, W. J. Henzel, T. M. Ayres, D. V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243 (10.1016/0092-8674(95)90149-3)
  44. Wang, C., M. Mayo, R. Korneluk, D. Goeddel, A. Baldwin. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress capase-8 activation. Science 281: 1680 (10.1126/science.281.5383.1680)
  45. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C. F. Ware, H. Yagita, K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271: 14661 (10.1074/jbc.271.25.14661)
  46. Aizawa, S., H. Nakano, T. Ishida, R. Horie, M. Nagia, K. Ito, H. Yagita, K. Okumura, J. Inoue, T. Watanabe. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF 2 are involved in CD30-mediated NFκB activation. J. Biol. Chem. 272: 2042 (10.1074/jbc.272.4.2042)
  47. Heath, W. R., C. Kurts, I. Caminschi, F. R. Carbone, J. F. Miller. 1999. CD30 prevents T-cell responses to non-lymphoid tissues. Immunol. Rev. 169: 23 (10.1111/j.1600-065X.1999.tb01303.x)
  48. Loenen, W. A.. 1998. CD27 and (TNFR) relatives in the immune system: their role in health and disease. Semin. Immunol. 10: 417 (10.1006/smim.1998.0159)
  49. Gravestein, L. A., J. Borst. 1998. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10: 423 (10.1006/smim.1998.0144)
  50. Chiarle, R., A. Podda, G. Prolla, J. Gong, G. J. Thorbecke, G. Inghirami. 1999. CD30 in normal and neoplastic cells. Clin. Immunol. 90: 157 (10.1006/clim.1998.4636)
  51. Saoulli, K., S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, T. H. Watts. 1998. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187: 1849 (10.1084/jem.187.11.1849)
  52. Duckett, C., C. Thompson. 1997. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11: 2810 (10.1101/gad.11.21.2810)
  53. Schwenzer, R., K. Siemienski, S. Liptay, G. Schubert, N. Peters, P. Scheurich, R. M. Schmid, H. Wajant. 1999. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase. J. Biol. Chem. 274: 19368 (10.1074/jbc.274.27.19368)
  54. Declercq, W., G. Denecker, W. Fiers, P. Vandenabeele. 1998. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor p75. J. Immunol. 161: 390 (10.4049/jimmunol.161.1.390)
  55. Lee, S. Y., D. R. Kaufman, A. L. Mora, A. Santana, M. Boothby, Y. Choi. 1998. Stimulus-dependent synergism of the anti-apoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways. J. Exp. Med. 188: 1381 (10.1084/jem.188.7.1381)
  56. Shi, C. S., J. H. Kehrl. 1997. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway. J. Biol. Chem. 272: 32102 (10.1074/jbc.272.51.32102)
  57. Chinnaiyan, A. M., K. O’Rourke, G.-L. Yu, R. H. Lyons, M. Garg, R. Duan, L. Xing, R. Gentz, J. Ni, V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990 (10.1126/science.274.5289.990)
  58. Rothe, M., V. Sarma, V. M. Dixit, D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269: 32767 (10.1126/science.7544915)
  59. VanArsdale, T. L., S. L. VanArsdale, W. R. Force, B. N. Walter, G. Mosialos, E. Keith, J. L. Browning, J. C. Reed, C. F. Ware. 1997. Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. USA 94: 2460 (10.1073/pnas.94.6.2460)
  60. Force, W. R., T. C. Cheung, C. F. Ware. 1997. Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272: 30835 (10.1074/jbc.272.49.30835)
  61. Eliopoulos, A. G., C. W. Dawson, G. Mosialos, J. E. Floettmann, M. Rowe, R. J. Armitage, J. Dawson, J. M. Zapata, D. J. Kerr, M. J. Wakelam, et al 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13: 2243
  62. Dürkop, H., H.-D. Foss, G. Demel, H. Klotzbach, C. Hahn, H. Stein. 1999. Tumor necrosis factor receptor-associated 1 is overexpressed in Reed-Sternberg cells of Hodgkin’s disease and Epstein-Barr virus-transformed lymphoid cells. Blood 93: 617 (10.1182/blood.V93.2.617.402k14_617_623)
  63. Siemienski, K., N. Peters, P. Scheurich, H. Wajant. 1997. Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosomes 9q33–34. Gene 195: 35 (10.1016/S0378-1119(97)00147-9)
Dates
Type When
Created 11 years, 4 months ago (April 20, 2014, 10:59 p.m.)
Deposited 8 months ago (Jan. 2, 2025, 12:33 p.m.)
Indexed 5 months ago (March 30, 2025, 6:09 a.m.)
Issued 24 years, 10 months ago (Nov. 1, 2000)
Published 24 years, 10 months ago (Nov. 1, 2000)
Published Print 24 years, 10 months ago (Nov. 1, 2000)
Funders 0

None

@article{Zapata_2000, title={TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies}, volume={165}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.165.9.5084}, DOI={10.4049/jimmunol.165.9.5084}, number={9}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Zapata, Juan M. and Krajewska, Maryla and Krajewski, Stanislaw and Kitada, Shinichi and Welsh, Kate and Monks, Anne and McCloskey, Natalie and Gordon, John and Kipps, Thomas J. and Gascoyne, Randy D. and Shabaik, Ahmed and Reed, John C.}, year={2000}, month=nov, pages={5084–5096} }